These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1053 related items for PubMed ID: 16636210

  • 21. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.
    Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A, SPORTIF Executive Steering Committee for the SPORTIF V Investigators.
    JAMA; 2005 Feb 09; 293(6):690-8. PubMed ID: 15701910
    [Abstract] [Full Text] [Related]

  • 22. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.
    Pharmacotherapy; 2007 May 09; 27(5):691-6. PubMed ID: 17461704
    [Abstract] [Full Text] [Related]

  • 23. Ximelagatran: a new oral anticoagulant.
    Hrebickova L, Nawarskas JJ, Anderson JR.
    Heart Dis; 2003 May 09; 5(6):397-408. PubMed ID: 14633322
    [Abstract] [Full Text] [Related]

  • 24. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH, Wheeldon NM.
    Clin Ther; 2004 Sep 09; 26(9):1470-8. PubMed ID: 15531009
    [Abstract] [Full Text] [Related]

  • 25. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.
    Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.
    J Am Coll Cardiol; 2009 Sep 08; 54(11):999-1002. PubMed ID: 19729116
    [Abstract] [Full Text] [Related]

  • 26. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
    Agarwal S, Hachamovitch R, Menon V.
    Arch Intern Med; 2012 Apr 23; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
    [Abstract] [Full Text] [Related]

  • 27. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.
    White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW.
    Arch Intern Med; 2007 Feb 12; 167(3):239-45. PubMed ID: 17296878
    [Abstract] [Full Text] [Related]

  • 28. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010 Feb 12; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 29. Trials and tribulations of non-inferiority: the ximelagatran experience.
    Kaul S, Diamond GA, Weintraub WS.
    J Am Coll Cardiol; 2005 Dec 06; 46(11):1986-95. PubMed ID: 16325029
    [Abstract] [Full Text] [Related]

  • 30. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG, Gulløv AL, Petersen P.
    Nord Med; 1996 Jun 06; 111(6):171-5. PubMed ID: 8700641
    [Abstract] [Full Text] [Related]

  • 31. Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study.
    Petersen P, Grind M, Adler J, SPORTIF II Investigators.
    J Am Coll Cardiol; 2003 May 07; 41(9):1445-51. PubMed ID: 12742279
    [Abstract] [Full Text] [Related]

  • 32. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V, Legnani C, Noventa F, Palareti G, ISCOAT Study Group.(Italian Study on Complications of Oral Anticoagulant Therapy).
    Thromb Haemost; 2001 Mar 07; 85(3):418-22. PubMed ID: 11307807
    [Abstract] [Full Text] [Related]

  • 33. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
    Scardi S, Giansante C.
    Ital Heart J Suppl; 2004 Sep 07; 5(9):705-11. PubMed ID: 15568608
    [Abstract] [Full Text] [Related]

  • 34. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
    Abdelhafiz AH, Wheeldon NM.
    Am J Geriatr Pharmacother; 2008 Mar 07; 6(1):1-11. PubMed ID: 18396243
    [Abstract] [Full Text] [Related]

  • 35. Ximelagatran in prevention of cardiovascular events.
    Molckovsky D, Boucher M.
    Issues Emerg Health Technol; 2004 Nov 07; (62):1-4. PubMed ID: 15565751
    [Abstract] [Full Text] [Related]

  • 36. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.
    Schulman S, Wåhlander K, Lundström T, Clason SB, Eriksson H, THRIVE III Investigators.
    N Engl J Med; 2003 Oct 30; 349(18):1713-21. PubMed ID: 14585939
    [Abstract] [Full Text] [Related]

  • 37. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
    Ford GA, Choy AM, Deedwania P, Karalis DG, Lindholm CJ, Pluta W, Frison L, Olsson SB, SPORTIF III, V Investigators.
    Stroke; 2007 Nov 30; 38(11):2965-71. PubMed ID: 17885258
    [Abstract] [Full Text] [Related]

  • 38. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
    Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S.
    Circulation; 2007 May 29; 115(21):2689-96. PubMed ID: 17515465
    [Abstract] [Full Text] [Related]

  • 39. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
    Hu DY, Zhang HP, Sun YH, Jiang LQ, Antithrombotic Therapy in Atrial Fibrillation Study Group.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr 29; 34(4):295-8. PubMed ID: 16776915
    [Abstract] [Full Text] [Related]

  • 40. Management of major bleedings during anticoagulant treatment with the oral direct thrombin inhibitor ximelagatran or warfarin.
    Fernlöf G, Sjöström BM, Lindell KM, Wall UE.
    Blood Coagul Fibrinolysis; 2009 Dec 29; 20(8):667-74. PubMed ID: 19741508
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.